Example: Heart Attack

Clinical Trials on Myotonic Disorders

Total 52 results





    • NCT00244413
      Completed
      Characteristics of Nondystrophic Myotonias
      Conditions: Nondystrophic Myotonias; Myotonia Congenita; Myotonic Disorders
    • NCT02398786
      Recruiting
      Myotonic Dystrophy Family Registry
      Conditions: Myotonic Dystrophy; Congenital Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Dystrophy 2; Dystrophia Myotonica; Dystrophia Myotonica 1; Dystrophia Myotonica 2; Myotonia Dystrophica; Myotonic Dystrophy, Congenital; Myotonic Myopathy, Proximal; PROMM (Proximal Myotonic Myopathy); Proximal Myotonic Myopathy; Steinert Disease; Steinert Myotonic Dystrophy; Steinert's Disease; Myotonia Atrophica
    • NCT00082108
      Recruiting
      Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
      Conditions: Myotonic Dystrophy; Facioscapulohumeral Muscular Dystrophy; Muscular Dystrophy; Myotonic Dystrophy Type 1; Myotonic Dystrophy Type 2; Congenital Myotonic Dystrophy; PROMM (Proximal Myotonic Myopathy); Steinert's Disease; Myotonic Muscular Dystrophy
    • NCT02336477
      Completed
      Mexiletine and Non Dystrophic Myotonias
      Conditions: Non-dystrophic Myotonias; Paramyotonia Congenita; Myotonia Congenita
    • NCT02251457
      Completed
      Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
      Conditions: Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1
    • NCT00004802
      Completed
      Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
      Conditions: Paralysis, Hyperkalemic Periodic; Hypokalemic Periodic Paralysis; Paramyotonia Congenita
    • NCT01939561
      Completed
      Lamotrigine as Treatment of Myotonia
      Conditions: Dystrophia Myotonica Type 1; Myotonia Congenita; Paramyotonia Congenita; Hyperkalemic Periodic Paralysis; Potassium-Aggravated Myotonia
    • NCT02375087
      Completed
      Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?
      Conditions: Myotonic Dystrophy
    • NCT02880735
      Unknown status
      Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
      Conditions: Myotonic Dystrophy 1; Steinert Disease
    • NCT03784586
      Recruiting
      Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients
      Conditions: Myotonic Dystrophy 1; Sudden Cardiac Death
    • NCT03211923
      Unknown status
      Muscle Relaxation in Myopathies With Positive Muscle Phenomena
      Conditions: Nemaline Myopathy Type 6; Myotonic Dystrophy Type 2; McArdle Disease
    • NCT02930408
      Terminated
      Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects
      Conditions: Steinert's Disease
    • NCT02708784
      Unknown status
      An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-
      Conditions: Glycogen Storage Disease Type 2; Dystrophia Myotonica
    • NCT03764150
      Recruiting
      Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years
      Conditions: Myotonic Dystrophy, Steinert
    • NCT01242007
      Completed
      Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients
      Conditions: Myotonic Dystrophy
    • NCT01931644
      Recruiting
      At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
      Conditions: All Diagnosed Health Conditions; ADD/ADHD; Alopecia Areata; Ankylosing Spondylitis; Asthma; Atopic Dermatitis Eczema; Beta Thalassemia; Bipolar Disorder; Breast Cancer; Celiac Disease; Cervical Cancer; Chronic Inflammatory Demyelinating Polyneuropathy; Chronic Kidney Diseases; Chronic Obstructive Pulmonary Disease; Colon Cancer; Colorectal Cancer; Crohn's Disease; Cystic Fibrosis; Depression; Diabetes Mellitus; Duchenne Muscular Dystrophy; Endometriosis; Epilepsy; Facioscapulohumeral Muscular Dystrophy; G6PD Deficiency; General Anxiety Disorder; Hepatitis B; Hereditary Hemorrhagic Telangiectasia; HIV/AIDS; Human Papilloma Virus; Huntington's Disease; Idiopathic Thrombocytopenic Purpura; Insomnia; Kidney Cancer; Leukemia; Lung Cancer; Lupus Nephritis; Lymphoma; Melanoma; Multiple Myeloma; Multiple Sclerosis; Myositis; Myotonic Dystrophy; Ovarian Cancer; Pancreatic Cancer; Parkinson's Disease; Polycystic Kidney Diseases; Prostate Cancer; Psoriasis; Psoriatic Arthritis; Rosacea; Scleroderma; Sickle Cell Anemia; Sickle Cell Trait; Sjogren's Syndrome; Skin Cancer; Spinal Muscular Atrophy; Systemic Lupus Erythematosus; Thrombotic Thrombocytopenic Purpura; Trisomy 21; Ulcerative Colitis
    • NCT03867435
      Recruiting
      Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
      Conditions: Myotonic Dystrophy Type-1; Myotonic Dystrophy Type-2
    • NCT02831504
      Unknown status
      PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
      Conditions: Myotonic Dystrophy Type 1
    • NCT02729597
      Completed
      Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study
      Conditions: Myotonic Dystrophy 1; Myotonic Dystrophy 2
    • NCT03603171
      Completed
      Clinical Outcome Measures in Myotonic Dystrophy Type 2
      Conditions: Myotonic Dystrophy Type 2
    • NCT03692312
      Not yet recruiting
      Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
      Conditions: Congenital Myotonic Dystrophy
    • NCT02312011
      Completed
      A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
      Conditions: Myotonic Dystrophy Type 1
    • NCT04003363
      Recruiting
      The United Kingdom National Registry for Myotonic Dystrophy
      Conditions: Myotonic Dystrophy
    • NCT04052958
      Enrolling by invitation
      DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1
      Conditions: Myotonic Dystrophy 1
    • NCT03981575
      Enrolling by invitation
      Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
      Conditions: Myotonic Dystrophy 1
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations